Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 2 25Phase 1 12Phase 1/2 11Phase 3 5Phase EARLY_PHASE1 4Phase 4 1Phase 2/3 1

Status

Recruiting 93Active not recruiting 35Not yet recruiting 25Completed 9Suspended 4Terminated 3Enrolling by invitation 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioblastoma 1Astrocytoma 1

Interventions

vocimagene amiretrorepvec 1Temozolomide 1Radiotherapy 1Radiation 1DNA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Withdrawn × 90 days × Clear all
NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

NRG Oncology

Phase 2/3 Withdrawn
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡